These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 17005277)

  • 1. New light for science: synchrotron radiation in structural medicine.
    Sorensen TL; McAuley KE; Flaig R; Duke EM
    Trends Biotechnol; 2006 Nov; 24(11):500-8. PubMed ID: 17005277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation damage to protein specimens from electron beam imaging and diffraction: a mini-review of anti-damage approaches, with special reference to synchrotron X-ray crystallography.
    Massover WH
    J Synchrotron Radiat; 2007 Jan; 14(Pt 1):116-27. PubMed ID: 17211078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flying under the radar: the new wave of BCR-ABL inhibitors.
    Quintás-Cardama A; Kantarjian H; Cortes J
    Nat Rev Drug Discov; 2007 Oct; 6(10):834-48. PubMed ID: 17853901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interplay of structural information and functional studies in kinase drug design: insights from BCR-Abl.
    Eck MJ; Manley PW
    Curr Opin Cell Biol; 2009 Apr; 21(2):288-95. PubMed ID: 19217274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Important therapeutic targets in chronic myelogenous leukemia.
    Kantarjian HM; Giles F; Quintás-Cardama A; Cortes J
    Clin Cancer Res; 2007 Feb; 13(4):1089-97. PubMed ID: 17317816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phasing macromolecular structures with UV-induced structural changes.
    Nanao MH; Ravelli RB
    Structure; 2006 Apr; 14(4):791-800. PubMed ID: 16615919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine kinase inhibitors for chronic myelogenous leukemia.
    Quintás-Cardama A; Kantarjian H; Cortes J
    N Engl J Med; 2007 Oct; 357(15):1557; author reply 1557-8. PubMed ID: 17933034
    [No Abstract]   [Full Text] [Related]  

  • 8. Automation of macromolecular crystallography beamlines.
    Arzt S; Beteva A; Cipriani F; Delageniere S; Felisaz F; Förstner G; Gordon E; Launer L; Lavault B; Leonard G; Mairs T; McCarthy A; McCarthy J; McSweeney S; Meyer J; Mitchell E; Monaco S; Nurizzo D; Ravelli R; Rey V; Shepard W; Spruce D; Svensson O; Theveneau P
    Prog Biophys Mol Biol; 2005 Oct; 89(2):124-52. PubMed ID: 15910915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCR-ABL in chronic myelogenous leukemia--how does it work?
    Goldman JM; Melo JV
    Acta Haematol; 2008; 119(4):212-7. PubMed ID: 18566539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing radiation damage in macromolecular crystals at synchrotron sources.
    Stern EA; Yacoby Y; Seidler GT; Nagle KP; Prange MP; Sorini AP; Rehr JJ; Joachimiak A
    Acta Crystallogr D Biol Crystallogr; 2009 Apr; 65(Pt 4):366-74. PubMed ID: 19307718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automation of X-ray crystallography.
    Abola E; Kuhn P; Earnest T; Stevens RC
    Nat Struct Biol; 2000 Nov; 7 Suppl():973-7. PubMed ID: 11104004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abl tyrosine kinase inhibitors for overriding Bcr-Abl/T315I: from the second to third generation.
    Tanaka R; Kimura S
    Expert Rev Anticancer Ther; 2008 Sep; 8(9):1387-98. PubMed ID: 18759691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic myelogenous leukemia progenitors display a genetically unstable personality.
    Rodrigues MS; Sattler M
    J Natl Cancer Inst; 2007 May; 99(9):662-3. PubMed ID: 17470729
    [No Abstract]   [Full Text] [Related]  

  • 15. Synchrotron and neutron techniques in biological crystallography.
    Blakeley MP; Cianci M; Helliwell JR; Rizkallah PJ
    Chem Soc Rev; 2004 Oct; 33(8):548-57. PubMed ID: 15480478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shedding UV light on the phase problem.
    Sussman JL; Silman I
    Structure; 2006 Apr; 14(4):629-30. PubMed ID: 16615902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural biology contributions to tyrosine kinase drug discovery.
    Cowan-Jacob SW; Möbitz H; Fabbro D
    Curr Opin Cell Biol; 2009 Apr; 21(2):280-7. PubMed ID: 19208462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
    Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-alpha may restore sensitivity to tyrosine-kinase inhibitors in Philadelphia chromosome positive acute lymphoblastic leukaemia with F317L mutation.
    Potenza L; Volzone F; Riva G; Soverini S; Martinelli S; Iacobucci I; Gnani A; Barozzi P; Forghieri F; Morselli M; Zanetti E; Maccaferri M; Baccarani M; Martinelli G; Torelli G; Luppi M
    Br J Haematol; 2009 Jul; 146(2):227-30. PubMed ID: 19545285
    [No Abstract]   [Full Text] [Related]  

  • 20. Applying the discovery of the Philadelphia chromosome.
    Sherbenou DW; Druker BJ
    J Clin Invest; 2007 Aug; 117(8):2067-74. PubMed ID: 17671641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.